axp1275
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2013 (NCT01890161)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- C-C chemokine receptor type 3INHIBITOR
CCR3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- axp1275
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01890161 | Phase 2 | Aug 1, 2013 | Axikin Pharmaceuticals, Inc., McMaster University, University of British Columbia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Axikin Pharmaceuticals, Inc. | For profit | 1 | 1 | 1 | 2013 |
| McMaster University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of British Columbia | Academic/Hospital | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1